0001209191-14-003731.txt : 20140117
0001209191-14-003731.hdr.sgml : 20140117
20140117161635
ACCESSION NUMBER: 0001209191-14-003731
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140115
FILED AS OF DATE: 20140117
DATE AS OF CHANGE: 20140117
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 14535321
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-01-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2014-01-15
4
M
0
7500
28.84
A
149000
D
Common Stock
2014-01-15
4
S
0
7500
78.67
D
141500
D
Common Stock
4770
I
401(k)
Common Stock
5568
I
Revocable Trust
Stock Option (right to buy)
28.84
2014-01-15
4
M
0
7500
0.00
D
2017-07-11
Common Stock
7500
16750
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $78.67 (range $78.29 to $79.05).
Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Fully vested.
Kenneth L. Horton, Attorney-In-Fact
2014-01-17